載入...
The potential of panobinostat as a treatment option in patients with relapsed and refractory multiple myeloma
Panobinostat is an investigational and potent histone deacetylase inhibitor (HDACi) that has shown promise as an antimultiple myeloma agent in the preclinical setting. In this review, we discuss the rationale for the use of panobinostat as a combination therapy for multiple myeloma and provide an ov...
Na minha lista:
| 發表在: | Ther Adv Hematol |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4250267/ https://ncbi.nlm.nih.gov/pubmed/25469210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620714552614 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|